Tetrahydroquinoline Synthesis via Chiral Proline Catalysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing tetrahydroquinoline (THQ) compounds are unable to produce enantiomerically pure THQs in the cis-2,3 and trans-3,4 configurations, which are essential for inhibitory activity on bromodomains and anti-inflammatory effects, as existing synthesis routes primarily yield trans-2,3 and trans-3,4 configurations.
Innovation Solution
A novel method involving a one-pot reaction using L-Proline and/or D-Proline with a Lewis acid, such as BF3·OEt2, to selectively produce THQs in the desired cis-2,3 and trans-3,4 configurations, allowing for the formation of enantiomerically pure compounds with one enantiomer predominating to at least 90% or greater.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If existing synthesis routes (Povarov reaction, sequential Mannich/Friedel-Craft reactions) are used, then THQ compounds can be produced, but only in trans-2,3 and trans-3,4 configurations, not in cis-2,3 and trans-3,4 configurations
Solution Approach 1:
The patent changes the reaction parameters by introducing chiral catalysts (Jacobsen's urea, phosphoric acid, silylated prolinol/POCl3) and modifying reaction conditions to achieve enantioselective formation of specific configurations (cis-2,3 and trans-3,4) that were previously inaccessible using conventional synthesis routes
Solution Approach 2:
The patent employs chiral catalysts as intermediary substances that mediate the formation of specific stereoisomers. These catalysts (Jacobsen's urea, phosphoric acid, silylated prolinol) act as mediators to control the stereochemistry of the reaction, enabling selective formation of cis-2,3 and trans-3,4 configurations
2Reliability
If conventional synthesis methods are used, then THQ compounds can be obtained, but enantiomerically pure compounds in cis-2,3 and trans-3,4 configurations cannot be produced
Solution Approach 1:
The patent modifies synthesis parameters by introducing chiral catalysts and specific reaction conditions that enable enantioselective formation of pure enantiomers in cis-2,3 and trans-3,4 configurations, achieving high reliability in stereochemical outcome
Solution Approach 2:
The patent segments the synthesis process into distinct steps with specific chiral catalysts for each configuration type, allowing independent optimization of enantioselectivity for cis-2,3 and trans-3,4 configurations
3Productivity
If multicomponent Povarov reaction is used, then THQ synthesis can be performed, but access to cis-2,3 and trans-3,4 configurations is not achieved
Solution Approach 1:
The patent changes the reaction parameters by introducing chiral catalysts (Jacobsen's urea, phosphoric acid, silylated prolinol/POCl3) that enable access to cis-2,3 and trans-3,4 configurations while maintaining the efficiency of multicomponent reactions
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the production of THQs with specific configurations that are crucial for therapeutic applications, including BET inhibition and anti-inflammatory effects, with improved efficiency and scalability, overcoming the limitations of previous synthesis routes.
Implementation Method 1
A novel method involving a one-pot reaction using L-Proline and/or D-Proline with a Lewis acid, such as BF3·OEt2, to selectively produce THQs in the desired cis-2,3 and trans-3,4 configurations
Implementation Method 2
A novel method involving a one-pot reaction using L-Proline and/or D-Proline with a Lewis acid, such as BF3·OEt2
Data Source
AI summary
The present invention relates to new tetrahydroquinoline (THQ) compounds and new methods for synthetizing such compounds.The present invention relates to the applications thereof, in particular in therapeutic treatment.The present invention relates in particular to compound having the following structure:wherein R, R′, RA, Nu, R1, R2, R3, and R4 are each independently an atom or a chemical group of atoms.